Immune & Anti-inflammatory
Thymosin Alpha-1
Thymic peptide approved in over 70 countries for chronic infections and cancer. It enhances the cellular immune response and modulates regulatory T cells.
Also known as: Tα1 · Thymalfasin · Zadaxin
Specifications
| Research area | Immune & Anti-inflammatory | ||
|---|---|---|---|
| Half-life | ~2 hours | ||
| Molecular weight | 3108.4 Da | ||
| Amino acid residues | 28 | ||
Research areas
ImmunityAntiviralAntitumourAutoimmunity
- Mechanism of action
- Activates the maturation and differentiation of T cells in the thymus via TLR2/TLR4. Increases the production of IL-2, type I and II interferons, and NK cells. Reduces tumor-induced immunosuppression and enhances immune surveillance.
- Reported research ranges
- 1.6 mg subcutaneously twice a week for 6 months (standard protocol).
- Reported adverse effects
- Excellent safety profile. Rarely: mild reaction at the injection site.
- Storage and handling
- Refrigerate at 2–8 °C after reconstitution. Powder is stable at room temperature.
This material is published for scientific and educational reference. It is not medical advice, not a treatment recommendation, and not an offer to sell. Compounds discussed are for research and laboratory use only.
← All compounds